The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 30, 2022

Filed:

Oct. 31, 2018
Applicant:

National University of Singapore, Singapore, SG;

Inventors:

Ashley Lauren St. John, Singapore, SG;

Mohamad Fadhli Bin Masri, Singapore, SG;

Abhay Rathore, Singapore, SG;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/517 (2006.01); A61P 31/14 (2006.01); A61K 31/138 (2006.01); A61K 31/225 (2006.01); A61K 31/343 (2006.01); A61K 31/4525 (2006.01); A61K 31/497 (2006.01);
U.S. Cl.
CPC ...
A61K 31/517 (2013.01); A61K 31/138 (2013.01); A61K 31/225 (2013.01); A61K 31/343 (2013.01); A61K 31/4525 (2013.01); A61K 31/497 (2013.01); A61P 31/14 (2018.01);
Abstract

The present invention relates to the use of serotonergic compounds for the treatment of virus-induced thrombocytopenia. More particularly, the invention relates to methods of treating thrombocytopenia by blocking serotonin activity. For example, inhibitors of receptor 5HT2A and/or receptor 5HT1A and/or inhibitors of mast cell degranulation and/or inhibitors of serotonin uptake may be used. Preferably, the thrombocytopenia is induced by dengue or Japanese Encephalitis virus, and the inhibitors are preferably ketanserin, WAY-100135, sarpogrelate, or fluoxetine.


Find Patent Forward Citations

Loading…